A M Soares Selected Research

Artificial Membranes (Artificial Membrane)

3/2001	Dissociation of enzymatic and pharmacological properties of piratoxins-I and -III, two myotoxic phospholipases A2 from Bothrops pirajai snake venom.
6/2000	Structural and functional characterization of BnSP-7, a Lys49 myotoxic phospholipase A(2) homologue from Bothrops neuwiedi pauloensis venom.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A M Soares Research Topics

Disease

13	Edema (Dropsy) 03/2017 - 01/2000
7	Myotoxicity 07/2016 - 03/2001
3	Necrosis 04/2001 - 07/2000
2	Snake Bites (Snake Bite) 07/2016 - 01/2013
2	Infections 10/2000 - 02/2000
1	Hypertension (High Blood Pressure) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Pain (Aches) 01/2017
1	Cardiotoxicity 01/2013
1	Nervous System Diseases (Neurological Disorders) 12/2007
1	Renal Insufficiency (Renal Failure) 12/2007
1	Hemorrhage 06/2001
1	Diarrhea 02/2001
1	Rupture 06/2000
1	Paracoccidioidomycosis (South American Blastomycosis) 02/2000

Drug/Important Bio-Agent (IBA)

4	AnticoagulantsIBA 03/2017 - 03/2001
4	Creatine Kinase (Creatine Phosphokinase)IBA 09/2016 - 06/2000
4	VenomsIBA 12/2007 - 06/2000
4	Liposomes (Liposome)IBA 03/2001 - 01/2000
3	Snake Venoms (Snake Venom)IBA 01/2017 - 03/2001
3	NeurotoxinsIBA 01/2014 - 08/2000
3	CrotoxinIBA 12/2007 - 09/2001
2	CytokinesIBA 09/2016 - 02/2000
2	Interleukin-6 (Interleukin 6)IBA 09/2016 - 07/2016
2	Phospholipases A2 (Phospholipase A2)IBA 07/2016 - 03/2001
2	bothropstoxin IIIBA 01/2014 - 08/2004
2	bothropstoxinIBA 01/2014 - 08/2004
2	Biological ProductsIBA 01/2011 - 08/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2001 - 02/2000
2	Artificial Membranes (Artificial Membrane)IBA 03/2001 - 06/2000
2	Interleukin-1beta (Interleukin 1 beta)IBA 07/2000 - 02/2000
1	CoagulantsIBA 03/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Neutralizing AntibodiesIBA 01/2014
1	Antivenins (Antivenoms)IBA 01/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Proteins (Proteins, Gene)FDA Link 08/2004
1	CarrageenanIBA 08/2004
1	Phospholipases AIBA 08/2004
1	Edetic Acid (EDTA)FDA Link 09/2001
1	neuwiedaseIBA 06/2001
1	Neuromuscular Agents (Skeletal Muscle Relaxants)IBA 03/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2001
1	PhytohemagglutininsIBA 10/2000
1	cyanoginosin LR (microcystin LR)IBA 07/2000
1	Heparin (Liquaemin)FDA LinkGeneric 06/2000

Therapy/Procedure

1	Traditional Medicine (Folk Remedies) 01/2013
1	Therapeutics 01/2013
1	Aftercare (After-Treatment) 09/2001
1	Subcutaneous Injections 06/2001
1	Intraperitoneal Injections 01/2000